Sacubitril

沙库巴曲

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameSacubitril
Drug Alias Namesacubitrilo沙库必曲沙库比曲sacubitrilumsacubitril +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeprilysin inhibitors
TargetsNeprilysin
Therapy Area/IndicationsInsulin ResistanceDiabetes MellitusMetabolic Diseases +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSlovakia +[26] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPending
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma AgUniversity Of Alabama At Birmingham
Inactive CompaniesVanderbilt University Medical Center
Active IndicationsInsulin ResistanceDiabetes MellitusMetabolic Diseases +[4] 
Inactive IndicationsEssential HypertensionHypertensionHeart Failure +[4] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG